Skip to main content
Clinical Trials/ISRCTN71877586
ISRCTN71877586Completed未知

A multi-centre randomised trial of insulin detemir in pre-diabetes associated with cystic fibrosis

Sheffield Children's NHS Foundation Trust (UK)0 sites240 target enrollmentStarted: June 27, 2007Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
240

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Any child over ten years of age with either fasting plasma glucose more than 6.1 mmol/l but less than 7.0 mmol/l and/or a two hour glucose of more than 7.8 mmol/l but less than 11.1 mmol/l.

Exclusion Criteria

  • 1. Failure to provide informed consent
  • 2. Pre-existing insulin or oral hypoglycaemic agent treatment

Investigators

Sponsor
Sheffield Children's NHS Foundation Trust (UK)

Similar Trials

Active, not recruiting
Phase 1
A multi-centre randomised trial of insulin detemir in pre-diabetes associated with cystic fibrosis. - Randomized trial of insulin detemir in CF associated pre-diabetesIndividuals with cystic fibrosis develop diabetes. They exhibit abnormal glucose handling (impaired glucose tolerance), poor growth and a decline in lung function before overt diabetes develops. Early treatment with insulin before diabetes develops may improve weight gain and lung function and delay progression to overt diabetes.
EUCTR2005-002997-31-GBSheffield Children's NHS Trust40
Completed
Not Applicable
Xience® or Vision® stent - Management of Angina in the elderlyCoronary diseaseacute coronary syndromesCirculatory SystemOther acute ischaemic heart diseases
ISRCTN92243650Brighton and Sussex University Hospitals NHS Trust (UK)800
Active, not recruiting
Not Applicable
A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection - SPARTACHIV infectionMedDRA version: 8Level: LLTClassification code 10020161
EUCTR2004-000446-20-IEImperial College360
Recruiting
Not Applicable
A multicenter controlled clinical trial on the improvement of sepsis-associated CCI muscular dystrophy by time-sharing administration(Day-3-Night-2) of Huanglian DecoctioSepsis-related Chronic Care Illnesses
ITMCTR2024000045Jiangsu Provincial Hospital of Chinese Medicine
Recruiting
Not Applicable
Ipilimumab plus nivolumab with prophlactic dexamethasone in patients with advanced renal cell carcinomaRenal cell carcinomaadvanced renal cell carcinomaD002292
JPRN-jRCTs041210108Hamamoto Shuzo90